Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

OBJECTIVE: Many studies have shown the efficacy of everolimus after pretreatment with vascular endothelial growth factor receptor-tyrosine kinase inhibitors. We investigated the efficacy and safety of everolimus as a second-line treatment after the failure of vascular endothelial growth factor recep...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Jpn J Clin Oncol
Egile Nagusiak: Oyama, Masafumi, Sugiyama, Takayuki, Nozawa, Masahiro, Fujimoto, Kiyohide, Kishida, Takeshi, Kimura, Go, Tokuda, Noriaki, Hinotsu, Shiro, Shimozuma, Kojiro, Akaza, Hideyuki, Ozono, Seiichiro
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5448062/
https://ncbi.nlm.nih.gov/pubmed/28334974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyw194
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak